News Sentiment

THAT sentiment intelligence

Thalia Therapeutics Plc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 54 Balanced news tone 9 relevant articles
Exchange LSE United Kingdom
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 0.01 Week of 10 Jul 2026
Weighted tone 54/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

85/100 classification confidence.

Company focus 9

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend active

+0.0% over one week, +13.0% over four weeks, trend active, and near fair-value range.

Latest direct headline Positive

UK BioTech Thalia Therapeutics raises €3.1 million and acquires Sanmirna Therapeutics

Market Reaction

Balanced read

55/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 85/100 classification
One-week reaction 0.0% Price digesting
Trend fit Trend active 13.0% over four weeks
Fair value -1.9% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 2
Neutral 7
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 9
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Proactive Investors 2
TradingView 2
BeBeez International 1
Market source 1
Proactive financial news 1
Hargreaves Lansdown 1
The Pharma Letter 1

Event Lens

What the news is about

Classified themes
Market update 7
Deals and strategy 2

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-9 of 9
The Pharma Letter Direct company coverage

Thalia Therapeutics

Tone
Neutral 50/100
Event
Market update
Published
26 Feb 2026 21:48
Source
The Pharma Letter